Literature DB >> 29504932

The inhibition of Caco-2 proliferation by astaxanthin from Xanthophyllomyces dendrorhous.

Kornchanok Wayakanon1, Kanjana Rueangyotchanthana2, Praween Wayakanon3, Chatrudee Suwannachart2.   

Abstract

PURPOSE: To investigate the efficiency of natural astaxanthin that has been extracted from Xanthophyllomyces dendrorhous in inhibiting the proliferation and viability of colorectal adenocarcinoma cell line (Caco-2; colon cancer cells).
METHODOLOGY: Caco-2 cells and normal human oralkeratinocytes (NOKs) were treated with different concentrations of extracted astaxanthin, ranging from 0.075 to 10 mg ml-1, for 24, 48 and 72 h. The number of cells was determined via MTS assay and the proliferating cells were investigated by bromodeoxyuridine (BrdU) assay.Results/Key findings. Of the Caco-2 cells, 30-50 % remained viable, while the NOKs showed 110-120 % survival when treated with 5 mg ml-1 astaxanthin. The Caco-2 cells showed distinct structural shrinkage when treated with the same concentration of astaxanthin. Fluorescent labelling of the DNA of the proliferative cells with BrdU showed a significant decrease in the number of the proliferative Caco-2 cells when the concentration of astaxanthin was increased to 5 mg ml-1.
CONCLUSION: The natural astaxanthin from X. dendrorhous, at an appropriate concentration, is effective in terminating the viability of, or retarding the proliferative activity of, Caco-2 cells, without harmful effects on NOKs.

Entities:  

Keywords:  Xanthophyllomyces dendrorhous; anti-oxidant; astaxanthin; colon cancer; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29504932     DOI: 10.1099/jmm.0.000710

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  1 in total

1.  Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6.

Authors:  Amirhossein Rastgar; Mahtab Sayadi; Gholamreza Anani-Sarab; Seyed Mehdi Sajjadi
Journal:  Mol Biol Rep       Date:  2022-04-20       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.